Searched for
AUROBINDO PHARMA ARM
Bombay HC backs GSK in Paxil trademark row against Shreya Life SciencesThe Indian subsidiary of the UK-based GSK PLC had urged the court to cancel the mark used by the local company in pharmaceutical and medici...- Aurobindo Pharma arm CuraTeQ gets Health Canada nod for biosimilarAurobindo Pharma announced a significant development today. Its subsidiary, CuraTeQ Biologics, has received a compliance notice from Health...
- Aurobindo Pharma arm gets USFDA nod for generic blood cancer drugAurobindo Pharma's subsidiary, Eugia Pharma Specialities Ltd, has secured USFDA approval to produce and sell generic Dasatinib tablets, use...
- USFDA issues Form 483 with 11 observations to Raleigh plant of Aurobindo Pharma armAurobindo Pharma Ltd announced that the USFDA issued a Form 483 with 11 observations following an inspection of its Aurolife Pharma LLC's R...
- USFDA flags Telangana unit of Aurobindo Pharma armThe letter, issued on August 15, was later made public by the USFDA, which stated that there was failure to ensure the accuracy of data in ...
- Aurobindo Pharma's Eugia Unit-3 gets warning letter from USFDA, shares fallAurobindo Pharma's subsidiary Eugia Pharma Specialities received a warning letter from the USFDA concerning its formulations manufacturing ...
- Aurobindo Pharma arm gets USFDA nod for Plerixafor injectionAurobindo Pharma said Plerixafor injection is indicated in combination with granulocyte-colony stimulating factor (G-CSF) to mobilise hemat...
- Aurobindo Pharma eyes $5-B revenue in 5 yearsAurobindo Pharma has undergone a significant reorganisation, restructuring its operations into three subsidiaries. Eugia Pharma Specialitie...
- Aurobindo Pharma arm gets USFDA nod for Sevelamer hydrochloride tabletsAurobindo Pharma Ltd on Wednesday said its wholly-owned subsidiary APL Healthcare has received a final approval from the US health regulato...
- Aurobindo Pharma arm signs pact with Medicines Patent Pool to develop anti-cancer drugIndia's Aurobindo Pharma has announced that its subsidiary Eugia Pharma Specialities has signed a voluntary sub-licensing agreement with Me...
- Aurobindo Pharma arm gets final US FDA nod for Vasopressin injectionNew Delhi, Aug 16 (PTI) Aurobindo Pharma Ltd on Tuesday said its wholly-owned arm Eugia Pharma Specialties Ltd has received final approval ...
- Sun Pharma, Aurobindo slide up to 2% as firms recall products in US marketAurobindo’s scrip fell to a low of Rs 612.60, 2 per cent lower than previous close on the National Stock Exchange, while Sun Pharma’s count...
- Aurobindo, Sun Pharma recall products in US marketAccording to the latest enforcement report issued by the US Food and Drug Administration (USFDA), the US-based arm of Aurobindo Pharma is r...
- Aurobindo Pharma arm enters pact to form JV in China with Luoxin"The percentage of shareholding in the joint venture company will be 30 per cent and 70 per cent between Helix and Luoxin," Aurobindo Pharm...
- Aurobindo Pharma to acquire under development product, related assets from Advent for $12.5mnThe acquisition is for a cash consideration of USD 12.5 million, it added. The indicative time period for completion of the acquisition is ...
- Aurobindo Pharma Q3 net profit at Rs 534.95 croreAurobindo Pharma today reported a consolidated net profit at Rs 534.95 crore for the third quarter ended December 31, 2015.
- Aurobindo Pharma gets tentative nod from USFDA for Lacosamide tabletsThis ANDA is at present under litigation in the United States District Court for the District of Delaware, Aurobindo Pharma said.
- Valuations of Aurobindo Pharma cheaper than many frontline peers; further upside likely: Anand TondonTondon said that he would not be surprised if the stock rallies further. He expects the US FDA clearance to make sure that earnings meet ex...
- Aurobindo Pharma is into a downtrend: CK Narayan"Aurobindo Pharma has been smashed a bit on news. The news is old or new but then the fact remains that the market has actually chosen to h...
- Aurobindo Pharma to divest Chinese armHyderabad-based Aurobindo Pharma has decided to disinvest its loss-making subsidiary in China while acquiring a small manufacturing unit in...
Load More
